Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Project Sage Oldco Inc SIENQ

Healthcare Medical Instruments & Supplies
Project Sage Oldco Inc., formerly Sientra, Inc., is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by... see more

Recent & Breaking News (PINL:SIENQ)

Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction

GlobeNewswire April 2, 2024

Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

GlobeNewswire February 13, 2024

Sientra Reports Third Quarter Financial and Operational Results

GlobeNewswire November 9, 2023

Sientra to Present at the Stifel 2023 Healthcare Conference

GlobeNewswire November 8, 2023

Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook

GlobeNewswire October 30, 2023

Sientra Reports Record Second Quarter Financial and Operational Results

GlobeNewswire August 10, 2023

Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023

GlobeNewswire July 27, 2023

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire June 30, 2023

Sientra Announces Appointment of Alexander W. Casdin to Board of Directors

GlobeNewswire June 20, 2023

Sientra Announces FDA-Clearance of Next Generation AlloX2 Pro(TM) Tissue Expander

GlobeNewswire June 8, 2023

Sientra Announces FDA-Clearance of Novel Portfinder(TM) Technology

GlobeNewswire May 17, 2023

Sientra Reports Record First Quarter 2023 Operational Results

GlobeNewswire May 11, 2023

Sientra to Report First Quarter 2023 Financial Results on May 11, 2023

GlobeNewswire May 1, 2023

Sientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market With New Product Launches

GlobeNewswire March 30, 2023

Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women's Access to Biologics for Soft Tissue Reconstruction

GlobeNewswire March 22, 2023

Sientra to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023

GlobeNewswire March 20, 2023

Sientra Announces Preliminary Results from Clinical Study and The First Shipment of Viality(TM) Fat Transfer System

GlobeNewswire March 1, 2023

Sientra Announces 1-for-10 Reverse Stock Split

GlobeNewswire January 20, 2023

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire December 29, 2022

Sientra Expands Global Footprint With Regulatory Approval to Market Breast Implants in the United Arab Emirates

GlobeNewswire December 13, 2022